According to Zhitong Finance App News, Baike Biotech (688276.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 270 million yuan, an increase of 50.64%; net profit attributable to shareholders of listed companies was 605.651 million yuan, an increase of 229.50% year on year; net profit attributable to shareholders of listed companies deducted 59.804 million yuan for non-recurring profit and loss, an increase of 228.87% year on year; basic earnings per share were 0.15 yuan/share.